BMRN
BIOMARIN PHARMACEUTICAL INC
NASDAQ · Healthcare · Biotechnology · US
$54.67
−0.02%Forward multiples
Based on analyst estimates
- P/E forward
- 8.42x
- P/E 2026E
- 10.82x
- P/E 2027E
- 8.30x
- P/E 2028E
- 6.93x
- P/S forward
- 2.40x
Trailing multiples
Trailing twelve months
- P/E TTM
- 143.87x
- PEG TTM
- 0.09x
- Price / book
- 1.67x
- Price / sales
- 3.11x
- Price / cash flow
- 12.35x
Enterprise value
- Enterprise value
- $13.9B
- EV / sales
- 4.08x
- EV / EBITDA
- 36.07x
- EV / EBIT
- 50.91x
- Market cap
- $10.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026